跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX GLENMARK 100 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX GLENMARK 100 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX GLENMARK 100 MG/ML SOLUCION INYECTABLE EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 22, 2023
Approval ID
047e91ab21fb8d3d
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
047e91ab21fb8d3d
Drug Cima Aemps Name
SUGAMMADEX GLENMARK 100 MG/ML SOLUCION INYECTABLE EFG
Register Number
88850
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2023-05-22
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
SUGAMMADEX SODIO
108,8 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 22, 2023
Approval ID
047e91ab21fb8d3d
Type
Standard
Back to CIMA-AEMPS Approvals
